| 发明名称 |
PHARMACEUTICAL COMBINATIONS COMPRISING CD33 ANTIBODIES AND DE-METHYLATING AGENTS |
| 摘要 |
The present invention relates to pharmaceutical combinations CD33 antibodies and de-methylating agents for use in treating diseases like MDS and cancer, especially AML. |
| 申请公布号 |
US2015125447(A1) |
申请公布日期 |
2015.05.07 |
| 申请号 |
US201414533136 |
申请日期 |
2014.11.05 |
| 申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
HEIDER Karl-Heinz |
| 分类号 |
A61K39/395;A61K31/706 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical combination comprising one or more CD33 antibodies and one or more de-methylating agents. |
| 地址 |
Ingelhaim am Rhein DE |
